Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
-
LYNPARZA™ approved by the US food and drug administration for the treatment of advanced ovarian cancer in patients with germline BRCA-mutations
-
Lynparza™approved in the European Union as first-in-class treatment for advanced BRCA-mutated ovarian cancer
-
AstraZeneca and Amgen to present detailed results from Phase III AMAGINE-1™ study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis
-
MOVENTIG® approved in the European Union for opioid-induced constipation
-
Jury verdict favours AstraZeneca in Nexium antitrust litigation
-
New Drug Application for IRESSA accepted by US Food and Drug Administration
-
AstraZeneca and Eli Lilly and Company initiate pivotal clinical trial for patients with early Alzheimer’s disease
-
AstraZeneca to collaborate with Cancer Research UK in screening for new cancer medicines at the AstraZeneca MRC UK Centre for Lead Discovery
-
MedImmune completes acquisition of Definiens
Latest articles and press releases
All of our latest press releases and articles are available to explore
